SOMANYCERA.BO(SOMANYCERA.BO)
SOMANYCERA.BO
No analyst ratings available
No analyst price targets available for SOMANYCERA.BO
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $31.16B | $33.58B | $35.71B |
| Low | $29.99B | $30.97B | $33.64B |
| High | $32.36B | $35.45B | $37.41B |
| EBITDA Avg | $2.89B | $3.11B | $3.31B |
| Low | $2.78B | $2.87B | $3.12B |
| High | $3.00B | $3.29B | $3.47B |
| EBIT Avg | $1.90B | $2.05B | $2.18B |
| Low | $1.83B | $1.89B | $2.05B |
| High | $1.97B | $2.16B | $2.28B |
| Net Income Avg | $1.10B | $1.34B | $1.69B |
| Low | $939M | $862M | $1.56B |
| High | $1.44B | $1.70B | $1.79B |
| EPS Avg | $26.70 | $32.68 | $41.13 |
| Low | $22.85 | $20.99 | $38.02 |
| High | $35.13 | $41.47 | $43.66 |
| Analysts (Rev / EPS) | 12 / 14 | 13 / 14 | 9 / 6 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $8.03B | $7.87B | $7.97B |
| Low | $8.03B | $7.87B | $7.97B |
| High | $8.03B | $7.87B | $7.97B |
| EBITDA Avg | $744M | $730M | $739M |
| Low | $744M | $730M | $739M |
| High | $744M | $730M | $739M |
| EBIT Avg | $490M | $480M | $486M |
| Low | $490M | $480M | $486M |
| High | $490M | $480M | $486M |
| Net Income Avg | $292M | $193M | $255M |
| Low | $292M | $193M | $255M |
| High | $292M | $193M | $255M |
| EPS Avg | $7.10 | $4.70 | $6.20 |
| Low | $7.10 | $4.70 | $6.20 |
| High | $7.10 | $4.70 | $6.20 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |